{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T05:18:45Z","timestamp":1677129525839},"reference-count":53,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Seit der letzten und gleichzeitig ersten Stellungnahme der deutschen ophthalmologischen Fachgesellschaften zu den M\u00f6glichkeiten der Minderung von Myopieprogression im Kindes- und\n          Jugendalter haben sich in der klinischen Forschung viele neue Details und Aspekte ergeben. Die nun vorliegende, zweite Stellungnahme aktualisiert das bisherige Dokuments und konkretisiert\n          die Empfehlungen sowohl zum Seh- und Leseverhalten als auch zu den pharmakologischen und optischen Therapieoptionen, die in der Zwischenzeit sowohl verfeinert als auch neu entwickelt\n          wurden.<\/jats:p>","DOI":"10.1055\/a-1998-9146","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T23:44:17Z","timestamp":1677109457000},"page":"190-197","source":"Crossref","is-referenced-by-count":0,"title":["Empfehlungen bei progredienter Myopie im Kindes- und Jugendalter"],"prefix":"10.1055","volume":"240","author":[{"name":"Berufsverband der Augen\u00e4rzte Deutschlands e.\u200aV. (BVA)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Deutsche Ophthalmologische Gesellschaft (DOG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Bielschowsky Gesellschaft f\u00fcr Schielforschung und Neuroophthalmologie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ophtha.2022.03.017","article-title":"Premyopia at preschool age: population-based evidence of prevalence and risk factors from a serial survey in Taiwan","volume":"129","author":"C Y Wang","year":"2022","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.63.1.8","article-title":"Annual incidences and progressions of myopia and high myopia in Chinese schoolchildren based on a 5-year cohort study","volume":"63","author":"S M Li","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ophtha.2020.07.017","article-title":"Evolution of the prevalence of myopia among Taiwanese schoolchildren: a review of survey data from 1983 through 2017","volume":"128","author":"T H Tsai","year":"2021","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10654-015-0010-0","article-title":"Prevalence of refractive error in europe: the European eye epidemiology (E(3)) consortium","volume":"30","author":"K M Williams","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00347-017-0601-0","article-title":"Analyse der Brillenst\u00e4rken zeigt keine Zunahme der Myopie in Deutschland von 2000 bis 2015","volume":"115","author":"W Wesemann","year":"2018","journal-title":"Ophthalmologe"},{"key":"ref6","first-page":"855","article-title":"Pr\u00e4valenz von Kurzsichtigkeit und deren Ver\u00e4nderung bei Kindern und Jugendlichen","volume":"117","author":"A K Schuster","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0043-102938","article-title":"Pr\u00e4valenz und Risikofaktoren der Kurzsichtigkeit bei Kindern und Jugendlichen in Deutschland \u2013 Ergebnisse der KiGGS-Studie","volume":"229","author":"A K Schuster","year":"2017","journal-title":"Klin Padiatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/opo.12817","article-title":"Longitudinal analysis of axial length growth in a German cohort of healthy children and adolescents","volume":"41","author":"C Truckenbrod","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaophthalmol.2016.4009","article-title":"Association of axial length with risk of uncorrectable visual impairment for europeans with myopia","volume":"134","author":"J WL Tideman","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"ref10","first-page":"312","article-title":"Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus","volume":"68","author":"B J Curtin","year":"1970","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ophtha.2015.04.017","article-title":"Incidence and characteristics of cataract surgery in France from 2009 to 2012: a national population study","volume":"122","author":"V Daien","year":"2015","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000513080","article-title":"Incidence of retinal detachment in Germany: results from the Gutenberg health study","volume":"244","author":"E Gerstenberger","year":"2021","journal-title":"Ophthalmologica"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10654-019-00512-7","article-title":"Interaction between lifestyle and genetic susceptibility in myopia: the generation R study","volume":"34","author":"C A Enthoven","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/opo.12579","article-title":"A genetic risk score and number of myopic parents independently predict myopia","volume":"38","author":"N Ghorbani Mojarrad","year":"2018","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ophtha.2014.04.017","article-title":"Myopia and level of education: results from the Gutenberg health study","volume":"121","author":"A Mirshahi","year":"2014","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1167\/iovs.13-13029","article-title":"Seasonal variations in the progression of myopia in children enrolled in the correction of myopia evaluation trial","volume":"55","author":"J Gwiazda","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"65.e1","DOI":"10.1016\/j.jaapos.2021.11.014","article-title":"Rapid progression of myopia at onset during home confinement","volume":"26","author":"C Picotti","year":"2022","journal-title":"J AAPOS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajo.2020.07.034","article-title":"Digital screen time during the COVID-19 pandemic: risk for a further myopia boom?","volume":"223","author":"C W Wong","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/25158414211059246","article-title":"Light and myopia: from epidemiological studies to neurobiological mechanisms","volume":"13","author":"A R Muralidharan","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/aos.15043","article-title":"A systematic review of near work and myopia: measurement, relationships, mechanisms and clinical corollaries","volume":"100","author":"S Gajjar","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/iovs.63.3.12","article-title":"Axial elongation during short-term accommodation in myopic and nonmyopic children","volume":"63","author":"R PJ Hughes","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2021.08.013","article-title":"Prevalence trend of myopia after promoting eye care in preschoolers: a serial survey in Taiwan before and during the Coronavirus disease 2019 pandemic","volume":"129","author":"Y C Yang","year":"2022","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: a report by the American academy of ophthalmology","volume":"124","author":"S L Pineles","year":"2017","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"J Huang","year":"2016","journal-title":"Ophthalmology"},{"issue":"01","key":"ref25","first-page":"CD4916","article-title":"Interventions to slow progression of myopia in children","author":"J J Walline","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jfo.2021.07.005","article-title":"Myopia progression and axial elongation in Spanish children: efficacy of atropine 0.01\u200a% eye-drops","volume":"44","author":"M Moriche-Carretero","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ceo.13736","article-title":"Western Australia atropine for the treatment of myopia (WA-ATOM) study: rationale, methodology and participant baseline characteristics","volume":"48","author":"S SY Lee","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bjophthalmol-2019-314819","article-title":"Low-dose (0.01\u200a%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol","volume":"104","author":"A Azuara-Blanco","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5\u200a%, 0.1\u200a%, and 0.01\u200a% doses (atropine for the treatment of myopia 2)","volume":"119","author":"A Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05\u200a%, 0.025\u200a%, and 0.01\u200a% atropine eye drops in myopia\n          control","volume":"126","author":"J C Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report","volume":"127","author":"J C Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"S Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41433-020-1122-7","article-title":"A 3-year follow-up study of atropine treatment for progressive myopia in Europeans","volume":"34","author":"J R Polling","year":"2020","journal-title":"Eye (Lond)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e7371","DOI":"10.1097\/MD.0000000000007371","article-title":"Atropine 0.5\u200a% eyedrops for the treatment of children with low myopia: a randomized controlled trial","volume":"96","author":"Y R Wang","year":"2017","journal-title":"Medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","article-title":"Side effects of topical atropine 0.05\u200a% compared to 0.01\u200a% for myopia control in German school children: a pilot study","volume":"41","author":"L Joachimsen","year":"2021","journal-title":"Int Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/jcm10040588","article-title":"Corneal penetration of low-dose atropine eye drops","volume":"10","author":"H Austermann","year":"2021","journal-title":"J Clin Med"},{"key":"ref37","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression","volume":"104","author":"A Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","article-title":"A pilot study on the efficacy and safety of 0.01\u200a% atropine in German schoolchildren with progressive myopia","volume":"8","author":"L Joachimsen","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01\u200a% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"O Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis","volume":"129","author":"A Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4274572","article-title":"Efficacy and adverse effects of atropine for myopia control in children: a meta-analysis of randomised controlled trials","author":"C Chen","year":"2021","journal-title":"J Ophthalmol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000523675","article-title":"Efficacy and safety of different add power soft contact lenses on myopia progression in children: a systematic review and meta-analysis","author":"Z Yu","year":"2022","journal-title":"Ophthalmic Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"3-year randomized clinical trial of misight lenses for myopia control","volume":"96","author":"P Chamberlain","year":"2019","journal-title":"Optom Vis Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40662-018-0106-1","article-title":"Relative peripheral refraction across 4 meridians after orthokeratology and LASIK surgery","volume":"5","author":"A Queir\u00f3s","year":"2018","journal-title":"Eye Vis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial","volume":"53","author":"P Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/opo.12621","article-title":"Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial","volume":"39","author":"P Sankaridurg","year":"2019","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00417-022-05573-1","article-title":"Comparison of peripheral refraction and higher-order aberrations between orthokeratology and multifocal soft contact lens designed with highly addition","volume":"260","author":"Y Huang","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12886-022-02310-4","article-title":"The effect of orthokeratology treatment zone decentration on myopia progression","volume":"22","author":"L Sun","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"ref49","first-page":"1110","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"C S Lam","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control vs. single-vision spectacle lenses: a randomized clinical trial","volume":"140","author":"J Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.9.9.11","article-title":"Effect of defocus incorporated multiple segments spectacle lens wear on visual function in myopic Chinese children","volume":"9","author":"C SY Lam","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00347-021-01452-y","article-title":"Myopietherapie und Prophylaxe mit \u201cDefocus Incorporated Multiple Segments\u201d-Brillengl\u00e4sern","volume":"118","author":"H Kaymak","year":"2021","journal-title":"Ophthalmologe"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICL.0000000000000746","article-title":"The efficacy of atropine combined with orthokeratology in slowing axial elongation of myopia children: a meta-analysis","volume":"47","author":"C Gao","year":"2021","journal-title":"Eye Contact Lens"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1998-9146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T23:45:38Z","timestamp":1677109538000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1998-9146"}},"subtitle":["Stellungnahme von DOG, BVA und der Bielschowsky Gesellschaft f\u00fcr Schielforschung und Neuroophthalmologie. Stand Juni 2022"],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,2,22]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1998-9146","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}